소아 화상환자에서 배양된 Acinetobacter baumannii에 대한 항생제 감수성 양상의 변화
The Changing Patterns of Antibiotic Susceptibility for Acinetobacter baumannii in Pediatric Burn Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose : Multidrug-resistant Acinetobacter baumannii (A. baumannii) is recognized to be the most difficult pathogen to control and treat in pediatric burn centers. We analyzed the antibiotic susceptibility pattern of A. baumannii in our pediatric burn intensive care unit during the past 7 years. Methods : We retrospectively evaluated 56 patients (105 samples) under the age 15 years and who were infected with A. baumannii between January 1999 and December 2005. Results : Fot the 56 patients, the ratio of males to females was 1.15:1 and the median age was 48.3 months. The sites of 105 isolates were wounds (65%), sputum (20%), blood (6 %), cutdown tips (5%), endo-tip tubes (2%) and urine (2%). A. baumannii presented yearround. The annual antimicrobial resistance rate increased and the multidrug resistant rate for two or more antibiotics was 93.33%. For 3 patients in whom resistance emerged, the interval period between the susceptible and resistant strains after antibiotic use was a mean of 10 days. The A. baumannii isolated from blood were all multi-drug resistant pathogens. Conclusion : Multidrug resistance of A. baumannii is increasing. Strict infection control guidelines and active surveillance are needed for the prevention and treatment of A. baumannii in hospitals. (Korean J Pediatr Infect Dis 2008;15:146-151)
Abstract
Purpose : Multidrug-resistant Acinetobacter baumannii (A. baumannii) is recognized to be the most difficult pathogen to control and treat in pediatric burn centers. We analyzed the antibiotic susceptibility pattern of A. baumannii in our pediatric burn intensive care unit during the past 7 years. Methods : We retrospectively evaluated 56 patients (105 samples) under the age 15 years and who were infected with A. baumannii between January 1999 and December 2005. Results : Fot the 56 patients, the ratio of males to females was 1.15:1 and the median age was 48.3 months. The sites of 105 isolates were wounds (65%), sputum (20%), blood (6 %), cutdown tips (5%), endo-tip tubes (2%) and urine (2%). A. baumannii presented yearround. The annual antimicrobial resistance rate increased and the multidrug resistant rate for two or more antibiotics was 93.33%. For 3 patients in whom resistance emerged, the interval period between the susceptible and resistant strains after antibiotic use was a mean of 10 days. The A. baumannii isolated from blood were all multi-drug resistant pathogens. Conclusion : Multidrug resistance of A. baumannii is increasing. Strict infection control guidelines and active surveillance are needed for the prevention and treatment of A. baumannii in hospitals. (Korean J Pediatr Infect Dis 2008;15:146-151)
참고문헌 (17)
- Agnihotri N, "Aerobic bacterial isolates from burn wound infections and their antibiograms-a five-year study", Burns, 30, pp.241~243 (2004)
- Song W, "Microbiologic aspects of predominant bacteria isolated from the burn patients in Korea", 27, pp.136~139 (2001)
- Hanlon GW, "The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting", Lett Appl Microbiol, 41, pp.375~378 (2005)
- Lyytikainen O, "Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem", J Hosp Infect, 31, pp.41~54 (1995)
- Jain R, "Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians", Ann Pharmacother, 38, pp.1449~1459 (2004)
- Appleman MD, "In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak", Antimicrob Agents Chemother, 44, pp.1035~1040 (2000)
- Go ES, "Clinical and molecular epidermiology of acinetobacter infections sensitive only to polymyxin B and sulbactam", Lancet, 344, pp.1329~1332 (1994)
- Perez F, "Global challenge of multidrugresistant Acinetobacter baumannii", Antimicrob Agents Chemother, 51, pp.3471~3484 (2007)
- Poirel L, "Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology", Clin Microbiol Infect, 12, pp.826~836 (2006)
- Taplin D, "The human skin as a sourse of Mima-Herella infections", JAMA, 186, pp.952~955 (1963)
- Wendt C, "Survival of Acinetobacter baumannii on dry surfaces", J Clin Microbiol, 35, pp.1394~1397 (1997)
- Seifert H, "Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods", J Clin Microbiol, 35, pp.2819~2825 (1997)
- Siegel RE, "Emerging gram-negative antibiotic resistance:daunting challenges, declining senstitvities, and dire consequences", Respir Care, 53, pp.471~479 (2008)
- Mussi MA, "Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins", Antimicrob Agents Chemother, 49, pp.1432~1440 (2005)
- Pankuch GA, "Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii", Antimicrob Agents Chemother, 52, pp.333~336 (2008)
- Chim H, "Five-year review of infections in a burn intensive care unit: High incidence of Acinetobacter baumannii in a tropical climate", Burns, 33, pp.1008~1014 (2007)
- McDonald CL, "Seasonal variation in Acinetobacter infection: 1987-19", Clin Infect Dis, 29, pp.1133~1137 (1999)